CVS Health Full Year 2024 Earnings: EPS Beats Expectations

Simply Wall St · 02/13 12:53

CVS Health (NYSE:CVS) Full Year 2024 Results

Key Financial Results

  • Revenue: US$372.8b (up 4.5% from FY 2023).
  • Net income: US$4.61b (down 45% from FY 2023).
  • Profit margin: 1.2% (down from 2.3% in FY 2023). The decrease in margin was driven by higher expenses.
  • EPS: US$3.67 (down from US$6.49 in FY 2023).
earnings-and-revenue-growth
NYSE:CVS Earnings and Revenue Growth February 13th 2025

All figures shown in the chart above are for the trailing 12 month (TTM) period

CVS Health EPS Beats Expectations

Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 20%.

Looking ahead, revenue is forecast to grow 4.6% p.a. on average during the next 3 years, compared to a 7.2% growth forecast for the Healthcare industry in the US.

Performance of the American Healthcare industry.

The company's shares are up 14% from a week ago.

Risk Analysis

Be aware that CVS Health is showing 2 warning signs in our investment analysis and 1 of those is potentially serious...